Skip to content
i2E
  • Programs
    • E3
    • Bridge2
    • ACT Tulsa
    • Love’s Entrepreneur’s Cup
    • OKBio
  • Client Portfolio
  • Services
    • Access to Funding
    • Venture Advisory Services
  • About
    • Our Values
    • Meet Our Team
    • Board of Directors
    • Corporate Partners
  • Contact
  • Media
  • Programs
    • E3
    • Bridge2
    • ACT Tulsa
    • Love’s Entrepreneur’s Cup
    • OKBio
  • Client Portfolio
  • Services
    • Access to Funding
    • Venture Advisory Services
  • About
    • Our Values
    • Meet Our Team
    • Board of Directors
    • Corporate Partners
  • Contact
  • Media
Search

Moleculera Labs gets i2E investment

Get in Touch

Courtesy of The Journal Record

OKLAHOMA CITY – The StartOK Accelerator Fund recently made a $270,000 investment in Oklahoma City-based Moleculera Labs.

Moleculera Labs is a life sciences company developing a test for children suffering from neurologic disorders associated with autoimmune conditions.

The StartOK Fund is managed by i2E.

The i2E investment closed a $540,000 financing round with co-investors that included SeedStep Angels and other out-of-state investors.

Moleculera Labs’ intellectual property is based on the work of Madeleine Cunningham and licensed from the University of Oklahoma.

The StartOK Fund is part of the $13.1 million Accelerate Oklahoma! initiative created by i2E in partnership with the Oklahoma Department of Commerce and the U.S. Treasury State Small Business Credit Initiative. i2E manages three funds under the Accelerate Oklahoma! program, including the GrowOK Fund and the OK Angel Sidecar Fund.

Craig Shimasaki is co-founder and CEO of Moleculera Labs. Cunningham is co-founder and chief scientific officer. – Staff report

Click here to read the article at the Journal Record website.

  • admin
    admin

More News

Loading...
headshot of Meredith Wilkerson
Blog, i2E
02.15.23

i2E Spotlight: Meredith Wilkerson, Life Sciences Venture Advisor & OKBio Director

Read more
Black doctor smiling with stethoscope
Blog, i2E
02.09.23

Titan Intake Automates Patient Referrals to Accelerate Care

Read more
man and woman reviewing paperwork at a table
Blog, i2E, News
01.10.23

Stories of Oklahoma Innovation: Building a Startup

Read more
woman in lab conducting a study
Blog, i2E
12.13.22

Bayesic Technologies Improves Effectiveness and Efficiency of Data Analysis in Healthcare

Read more
Bison grazing fields
Blog
11.30.22

Bison Underground Merges Nature, Science, and Technology to Tackle Climate Change

Read more
African American family sitting on couch reading and chatting
Blog, E3, i2E
11.22.22

Fokes Connects Families, Caregivers and Care Agencies for Smoother Communications and Care 

Read more
i2e blog post graphic
Blog, News
11.03.22

Introducing: Stories of Oklahoma Innovation

Read more
Default Featured Image
OKBio
06.28.22

Oklahoma Grown! i2E Invests in BIO startups

Read more
Default Featured Image
OKBio
06.13.22

Oklahoma Medical Research Foundation BIO

Read more
Default Featured Image
OKBio
06.13.22

Moleculera Labs BIO

Read more
Default Featured Image
OKBio
06.13.22

University of Oklahoma Health Sciences Center BIO

Read more
Default Featured Image
OKBio
06.13.22

Oklahoma State University BIO

Read more
i2E

Oklahoma City Office

840 Research Parkway, Suite 250
OKC, OK 73104
+1 (405) 235.2305

Tulsa Office

100 S. Cincinnati Ave – Suite 514
Tulsa, OK 74103
+1 (918) 582.5592

  • Client Portfolio
  • About Us
  • Media
  • Events
  • Contact
  • Resources

© 2023 i2E Privacy Policy

Follow us:

Linkedin Twitter Facebook Instagram

Programs

  • E3
  • Bridge2
  • ACT Tulsa
  • Love's Entrepreneur's Cup
  • OKBio
  • Client Portfolio

Services

  • Access to Funding
  • Venture Advisory Services
  • Contact
  • About
  • Our Values
  • Our Team
  • Board of Directors
  • Corporate Partners
  • Media
i2E